Call for Applications for the 2016 Capital Access Advisory Program

Initiated in 2013, the OBIO Capital Access Advisory Program operates downstream from other programs and targets the critical issue of access to capital at the Series A to later stages of venture financing.  All high-potential bioscience companies based in Ontario that meet the requirements listed below are encouraged to apply.  

OBIO CAAP Eligibility
•    Companies focused on developing life science products or services including but not limited to therapeutics, medical devices, diagnostics, or healthcare information technologies, and
•    Enterprises that have already raised initial capital and are committed to raising a Series A or subsequent round of financing in the next 12 to 18 months.

The deadline for 2016 CAAP Applications was December 23rd, 2015 at 5 pm ET.

Information Session  
An information session for companies applying to OBIO CAAP was held on November 16, 2015 at 12 pm by teleconference, and the slides are available here.  For any questions about CAAP, please contact

OBIO has received investment from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) for CAAP®